Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting its stock by 6.87% as the drug exhibits …
Latest in Business
-
-
Trade tensions rise as Trump considers tariffs on China and the EU. Canada warns of countermeasures, while China calls for …
-
The Dow surged 244 points as President Trump’s softer tariff approach reassured investors, with major indices rising on tempered fears …
-
Beijing struggles to stabilize the yuan as Trump tariffs and a strong U.S. dollar intensify pressures on China’s economy, raising …
-
The 10-year Treasury yield hit a 14-month high as investors await inflation reports, with key data on producer and consumer …
-
Nvidia stock dipped 6.2% after CES, but analysts emphasize the company’s AI leadership, highlighting advancements like the Blackwell AI processor …
-
Chinese stocks face mounting pressure as Tencent and CATL shares fall following U.S. military ties allegations, raising global investor concerns …
-
Oil prices fell 1% amid weak economic data from the US and Germany, reversing recent gains driven by a weaker …
-
South Korea’s foreign reserves increased slightly in December but fell to their lowest year-end level in five years, reflecting currency …
-
Oil prices surged to multi-month highs as US crude stockpiles fell for the sixth straight week, boosting WTI and Brent …